The exceptional NF-κB pathway is known as a crucial participant in cell proliferation and EMT in bladder cancer, and blockade of the NF-κB pathway could inhibit tumorigenesis and the progression of malignancies [26–28]. Here, NFKB1 is linked to urinary bladder cancer.